Chemical Genomics Strategy for the Discovery of New Anticancer Agents

Author(s): Mankil Jung, Hanjo Kim, Myosun Kim.

Journal Name: Current Medicinal Chemistry

Volume 10 , Issue 9 , 2003

Submit Manuscript
Submit Proposal


Chemical genomics represents a cooperation of biology and chemistry to identify and intervene the biological targets. Small molecules with diverse structural characteristics should be used to validate the target through interfering with the biological processes. Because of the limitation of existing chemical libraries, the diversity can be exploited using both the molecular design techniques; structure-based design and ligand-based design. These methods can guide the selection of small molecules with optimal binding properties to desired biological targets. Studies of potential molecular targets for novel anticancer drug discovery including in silico screening, QSAR, and de novo design demonstrated the importance of chemical genomics strategy to find the chemical probes and drug lead compounds.

Keywords: Chemical Genomics, Anticancer Agents, silico screening

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Page: [757 - 762]
Pages: 6
DOI: 10.2174/0929867033457782
Price: $58

Article Metrics

PDF: 2